Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Sorafenib can cause a unique skin reaction.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

Upadacitinib may effectively treat alopecia areata without side effects.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Finasteride may help treat childhood brain tumors by activating certain genes.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Cnicus Benedictus leaf extract can kill cervical cancer cells without harming normal cells.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Cancer prevention has advanced significantly, with some strategies proving successful.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.